The Great Chinese AI IPO Rush
Two of China's most formidable AI labs are sprinting toward the public markets in what analysts are calling the most significant test yet of whether Western money will fund Chinese AI companies that the US government is actively targeting.
Moonshot: From $30B to $50B in Two Months
Moonshot AI, the Beijing-based startup behind the Kimi K3 model that shocked Silicon Valley earlier this month, is preparing a Hong Kong listing within six months at a valuation of up to $50 billion — up from roughly $30 billion in June.
The valuation leap is entirely driven by Kimi K3, a 2.8 trillion-parameter model that topped multiple AI benchmarks after its July 16 release and briefly rattled US stock markets. Demand has been so intense that Moonshot paused new subscriptions two days after launch because it ran out of computing capacity.
Yet the model is already a serious business. Kimi K3 has pushed Moonshot's annualized revenue to $300 million, giving the company real financial heft behind the hype. Moonshot has promised to release Kimi K3's open weights on July 27, letting anyone run the model themselves.
DeepSeek: The National Champion Route
DeepSeek, widely seen as China's most technically respected AI lab, is taking a different path. It is pursuing a listing on Shanghai's STAR Market — China's Nasdaq-style tech board — at a valuation of up to $71 billion, targeting a debut as early as the second quarter of 2027.
The choice of Shanghai over Hong Kong is a deliberate strategic signal. Shanghai's market is where China lists its "national champions" — companies considered strategically important or that replace foreign technology restricted by US export controls. By choosing Shanghai, DeepSeek positions itself as a state-backed crown jewel.
Today, July 24, DeepSeek officially launched V4, its new stable model family. The cheaper V4-Flash costs just $0.14 per million input words and $0.28 per million output words — roughly 100 times cheaper than comparable top-tier US models. Despite the price, its top version scores 80.6% on a respected software engineering test, matching Google's Gemini.
A Wave, Not Isolated Events
This is part of a broader surge. MiniMax and Z.ai already listed in Hong Kong in January. Moonshot is reportedly in talks to finalize a pre-IPO funding round before listing. CXMT, the world's fourth-largest DRAM manufacturer, begins trading on Shanghai's STAR Market on July 27 with an $8 billion IPO.
The timing lines up with the American side too. OpenAI and Anthropic are both preparing US IPOs, meaning the second half of 2026 will put a real market price on AI companies on both sides of the Pacific.
The Elephant in the Room: The Copying Accusation
All of this is unfolding against the backdrop of a White House accusation that Moonshot copied Anthropic's technology to build Kimi K3, and claims it obtained restricted Nvidia chips through Thailand.
Moonshot has not responded publicly to either accusation — a silence that investors will have to weigh as they evaluate the IPO. The unresolved questions create real tension: on one hand, Kimi K3 drove the value from $30 billion to $50 billion. On the other, a US official has publicly claimed the model was built on stolen technology.
Adding to the irony, Cursor — the AI coding tool that SpaceX is acquiring for roughly $60 billion — admitted back in March that it was built using a Kimi model from Moonshot as its foundation.
What to Watch
- July 27: Kimi K3's open weights become freely downloadable - Before August 1: White House expected to announce new AI rules - Moonshot's response (or silence) to the copying accusation will shape investor confidence - DeepSeek V4 pricing will pressure the entire industry's cost structure
As one analyst put it: "AI used to be decided in research labs. Now it is decided in stock listings and government statements too. For the rest of 2026, the money and the politics matter as much as the models."
